Systolic blood pressure · general population including those at moderate to high risk of CVD, mean age between 30 and 75
1 finding from 1 review
Diastolic blood pressure · general population including those at moderate to high risk of CVD, mean age between 30 and 75
1 finding from 1 review
Effect on later sexual function · participants with cardiovascular disease
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Sexual satisfaction · participants with cardiovascular disease
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Marital/relationship/partner satisfaction (secondary outcome) · participants with cardiovascular disease
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Quality of life · participants with cardiovascular disease
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Anxiety · participants with cardiovascular disease
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Resumption of sexual activity after a cardiac event (Resumption of sex) · participants with cardiovascular disease
1 finding from 1 review
no estimate extracted
1 study · 4 participants
Very low
Satisfaction in how sexual issues are addressed in cardiac rehabilitation services (Satisfaction with health services) · participants with cardiovascular disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality (all‐cause) · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in mortality (all‐cause) compared with any control treatment (moderate certainty).
1 finding from 1 review
Cardiovascular mortality · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in mortality (cardiovascular) compared with any control treatment (moderate certainty).
1 finding from 1 review
Myocardial infarction · any patient population and people with high cardiovascular risk
Colchicine probably leads to lower myocardial Infarction (total) compared with any control treatment (moderate certainty).
1 finding from 1 review
Adverse event (total) · any patient population and people with high cardiovascular risk
It is very uncertain whether colchicine changes adverse event (total) compared with any control treatment (very low certainty).
1 finding from 1 review
Gastrointestinal adverse events · any patient population and people with high cardiovascular risk
Colchicine may leads to higher adverse event (gastrointestinal) compared with any control treatment (low certainty).
1 finding from 1 review
Adverse event (serious) · any patient population and people with high cardiovascular risk
1 finding from 1 review
Heart failure · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in heart failure (total) compared with any control treatment (low certainty).
1 finding from 1 review
Stroke · any patient population and people with high cardiovascular risk
Colchicine showed no clear difference in stroke (total) compared with any control treatment (low certainty).
1 finding from 1 review
All‐cause short‐term mortality · people with unexplained recurrent syncope
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
All‐cause long‐term mortality · people with unexplained recurrent syncope
It is very uncertain whether summary of findings for the main comparison. Implantable loop recorder changes all‐cause long‐term mortality compared with conventional diagnostic workup (very low certainty).
1 finding from 1 review
Other adverse events · people with unexplained recurrent syncope
1 finding from 1 review